Literature DB >> 2049992

Visual and brainstem auditory evoked potentials in hereditary motor-sensory neuropathy.

J W Kowalski1, M Rasheva, B Zakrzewska.   

Abstract

Visual evoked potentials (VEP) and brainstem auditory evoked potentials (BAEP) were recorded in 57 children and adults with hereditary motor-sensory neuropathy (HMSN); 37 of them were diagnosed as type I (demyelinating) and 20 as type II (axonal). None of the patients presented central nervous system involvement. The results were compared with VEP and BAEP records of 12 adults with Guillain-Barré syndrome (GBS) and 40 healthy controls. Above 30% of all patients with HMSN I showed delayed latency of the VEP. These abnormalities were less expressed in HMSN II. Abnormal BAEP were observed in almost 50% of patients with HMSN I and HMSN II with nearly the same frequency in both types but more pronounced in HMSN I. The most common feature was prolongation of the I-III interpeak latency (JPL). The VEP and BAEP changes could be present simultaneously in the same patient (mainly in HMSN I) or separately. More often the abnormalities were observed in the adult patients. Normal VEP and BAEP values were present in all patients with GBS. The results strongly suggest the subclinical optical and auditory pathways involvement in HMSN patients.

Entities:  

Mesh:

Year:  1991        PMID: 2049992

Source DB:  PubMed          Journal:  Electromyogr Clin Neurophysiol        ISSN: 0301-150X


  3 in total

Review 1.  Brain stem evoked potentials in childhood neurological diseases.

Authors:  R Kalmanchey
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

2.  Slowing of central conduction in X-linked Charcot-Marie-Tooth neuropathy shown by brain stem auditory evoked responses.

Authors:  G Nicholson; A Corbett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

3.  F response and somatosensory and brainstem auditory evoked potential studies in HMSN type I and II.

Authors:  V Scaioli; D Pareyson; G Avanzini; A Sghirlanzoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.